|
||
Article |
Splicing-independent recruitment of spliceosomal small nuclear RNPs to nascent RNA polymerase II transcripts
Correspondence to Michel Bellini: bellini{at}life.uiuc.edu
In amphibian oocytes, most lateral loops of the lampbrush chromosomes correspond to active transcriptional sites for RNA polymerase II. We show that newly assembled small nuclear ribonucleoprotein (RNP [snRNP]) particles, which are formed upon cytoplasmic injection of fluorescently labeled spliceosomal small nuclear RNAs (snRNAs), target the nascent transcripts of the chromosomal loops. With this new targeting assay, we demonstrate that nonfunctional forms of U1 and U2 snRNAs still associate with the active transcriptional units. In particular, we find that their association with nascent RNP fibrils is independent of their base pairing with pre–messenger RNAs. Additionally, stem loop I of the U1 snRNA is identified as a discrete domain that is both necessary and sufficient for association with nascent transcripts. Finally, in oocytes deficient in splicing, the recruitment of U1, U4, and U5 snRNPs to transcriptional units is not affected. Collectively, these data indicate that the recruitment of snRNPs to nascent transcripts and the assembly of the spliceosome are uncoupled events.
| Introduction |
|---|
|
|
|---|
Although data on the spatial and temporal recruitment of splicing factors onto a template pre-mRNA abound, very little is still known about the essential characteristics of a spliceosomal snRNP that contribute in vivo to its association with nascent transcripts. Previous work on U1 and U2 snRNPs highlighted the importance of the base pairing of their RNA moieties to cis-acting sequences on pre-mRNAs, the intronic 5' splice site (SS) and the branch point sequence (BPS), respectively (Krämer et al., 1984; Parker et al., 1987; Wu and Manley, 1989; Zhuang and Weiner, 1989). In the case of the U1 snRNP, however, it was shown that the base pairing of its 5' end with the 5' SS is only one of several interactions that contribute to the formation of a U1 snRNP–pre-mRNA complex (Du and Rosbash, 2001) and occurs after an initial recruitment of the U1 snRNP (Lacadie and Rosbash, 2005). Interestingly, cleavage of the 5' end of the U1 small nuclear RNA (snRNA) has no effect on the rate of association of the U1 snRNP with a consensus 5' SS RNA oligonucleotide in vitro (Rossi et al., 1996). Rather, recognition of the 5' SS by the U1 snRNP appears to be driven by its overall protein complement. Which of the several U1 snRNP proteins and which sequence elements of the U1 snRNA are critical for its targeting to nascent transcripts is still unclear, however. The same question also remains unanswered for the other spliceosomal snRNPs, and, in light of their complex intranuclear trafficking before engaging pre-mRNA splicing (for review see Kiss, 2004), it cannot be addressed directly using in vitro systems.
The lampbrush chromosomes (LBCs) of amphibian oocytes exhibit unique structural characteristics that make it possible to study the recruitment of snRNPs to nascent transcripts in vivo. In particular, these extended diplotene bivalent chromosomes display numerous lateral loops of chromatin that correspond to regions of intense transcriptional activity by RNAPII (for review see Morgan, 2002). The chromosomal loops are composed of two distinct domains: the first domain corresponds to a decondensed euchromatin axis that can be demonstrated using antibodies against the RNAPII transcriptional machinery or various chromatin components (Gall et al., 1999). The second domain corresponds to nascent RNP fibrils, which are formed from nascent pre-mRNAs associated with a cortege of factors involved in their maturation. These RNP fibrils create a dense RNP matrix around the loop axis that is readily observable by phase contrast or differential interference contrast (DIC) microscopy. Indeed, the elongation of transcripts along the axis is reflected in a characteristic thin to thick morphology of the loops (Gall et al., 1999; Beenders et al., 2003; for review see Morgan, 2002). We show here for the first time that newly assembled snRNPs, which are formed upon cytoplasmic injection of fluorescein-labeled snRNAs, associate rapidly with nascent transcripts, and we used this novel cytological assay to begin dissecting the molecular mechanisms that regulate the association of splicing snRNPs with active transcriptional units. In particular, we demonstrate that U1 and U2 snRNPs need not be functional for their association with elongating transcripts. We also characterize the first stem loop domain of the U1 snRNA as a structure that is both necessary and sufficient for targeting the U1 snRNP to nascent pre-mRNAs. Finally, we present evidence that pre-mRNA splicing occurs on the LBC loops and that recruitment of the splicing snRNPs to active transcriptional units is independent of their integration into a spliceosome.
| Results |
|---|
|
|
|---|
Chromosomal loops are likely sites of pre-mRNA processing, however, and because injected synthetic spliceosomal RNAs can rescue splicing in oocytes depleted of the corresponding endogenous snRNA (Pan and Prives, 1988; Yu et al., 1998), our hypothesis was that injected fluorescent snRNAs do associate with chromosomal loops but at a concentration too low to be detected without amplification. To test that idea, fluorescein-conjugated U1, U2, U4, and U5 snRNAs were synthesized and injected into the cytoplasm of Xenopus laevis oocytes, and their was fate monitored over time on fixed nuclear spreads. A two-antibody detection system was used to enhance the fluorescent signals, and, as expected, all four snRNAs entered the nucleus and associated with CBs. Fig. 1 shows the targeting of the U1 snRNP to both CBs and IGCs only 1 h after cytoplasmic injection. The same result was obtained with U2, U4, and U5 snRNAs. In contrast, the nonspliceosomal U7 snRNP (discussed in the next paragraph), which was used here as a negative control, did not associate with IGCs but strongly targeted CBs.
|
|
The chromosomal targeting of fluorescent snRNPs requires RNAPII transcripts
To further test whether snRNPs are recruited to active sites of transcription, oocytes were treated with the transcription inhibitor actinomycin D before nuclear spread preparation. Such treatment results in a complete loss of chromosomal signal, as shown in Fig. 3 A for the U1 snRNP.
These data further support the conclusion that association of the fluorescent snRNPs with chromosomes depends on the presence of nascent transcripts. Although there is no RNAPI activity on LBCs, both RNAPII and RNAPIII are actively engaged in transcription. The sites of RNAPIII transcription have been mapped to
90 distinct chromosomal loci (Murphy et al., 2002). These sites are not visible by light microscopy because they lack the density of an RNP matrix but are readily detected by immunofluorescence using anti-RNAPIII antibodies (Murphy et al., 2002). An antibody directed against one of the specific subunits of RNAPIII, RPC53, was used in Fig. 3 B to show that a newly assembled fluorescent U1 snRNP does not associate with RNAPIII transcriptional units. This result is in agreement with the fact that RNAPIII transcripts are not substrates of the spliceosome. Identical results were obtained with the U2 snRNP (unpublished data).
|
Nonfunctional U1 and U2 snRNPs are still recruited to nascent transcripts
U1 and U2 snRNPs are thought to be involved early in the stepwise formation of the spliceosome onto a target pre-mRNA, and they both display a short sequence that hybridizes to the 5' SS or BPS of an intron, respectively (for review see Patel and Steitz, 2003). In the case of the U1 snRNA, the 5' SS recognition sequence lies within its first 20 nucleotides. To test whether the recruitment of the U1 snRNP to transcriptional units requires its hybridization with pre-mRNAs, a fluorescent U1 snRNA truncated from its first 20 residues, U1(
SS) snRNA, was synthesized and injected into the cytoplasm of Xenopus oocytes. It was established that removal of these residues of the U1 snRNA does not prevent the assembly of a U1(
SS) snRNP with its full protein complement (Rossi et al., 1996; Du and Rosbash, 2001), and, as expected, the newly made U1(
SS) snRNP was rapidly recruited to the nucleus. Interestingly, in addition to accumulating within CBs and IGCs, the U1(
SS) snRNP targeted the chromosomal loops just as well as the full-length U1 snRNP (Fig. 4).
A similar deletion analysis was performed for the U2 snRNP in which the BPS recognition sequence was removed. Such a U2(
BPS) snRNA can no longer engage splicing by hybridizing with an intronic BPS, yet the newly formed U2(
BPS) snRNP associates with chromosomal loops as well as with CBs and IGCs, identical to wild-type U2 snRNP (Fig. 4). Together, these data demonstrate that the recruitment of U1 and U2 snRNPs to nascent transcripts is not directed by hybridization of their snRNA moieties to cis-acting signals on pre-mRNAs. Importantly, they also highlight the fact that the association of U1 and U2 snRNPs with elongating transcripts can be uncoupled from their function in splicing.
|
29) snRNA), injected it into the cytoplasm of stage V oocytes, and analyzed its nuclear distribution 18 h later on nuclear spreads. Fig. 5 shows that the newly assembled U2(
29) snRNP associates well with the chromosomal loops, further supporting the idea that the association of snRNPs with active RNAPII transcriptional units is independent of their ability to engage splicing.
In addition, IGCs are brightly labeled, but, surprisingly, CBs appear to be only weakly stained (Fig. 5, arrow), especially when the fluorescent signal is compared with that of the full-length U2 snRNP (Fig. 2). Because CBs are implicated in the internal modification of the spliceosomal snRNAs, one possible explanation is that lack of the first 29 residues, among which many are modified, renders the U2(
29) snRNA a poor substrate for the modification machinery and, as a result, reduces its overall residence time within CBs.
|
47) snRNA was injected into the cytoplasm of stage V oocytes. Nuclear spreads were prepared 18 h later. Fig. 6 A shows that U1(
47) snRNP accumulates in CBs but fails to associate with both IGCs and the nascent transcripts on chromosomal loops.
Because the removal of the first 20 residues of the U1 snRNA does not disrupt its chromosomal targeting (Fig. 4), we concluded that stem loop I is the structure present within the first 47 nucleotides that is critical for the association of the U1 snRNP with nascent transcripts. To test that idea, we constructed a chimeric RNA by fusing stem loop I to the 3' end of the U7 snRNA, which is exclusively found associated with CBs (Figs. 1 and 2). The resulting U7/U1(I) snRNA was injected into stage V oocytes, and its subnuclear distribution was analyzed on nuclear spreads (Fig. 6 B). Remarkably, stem loop I alone is sufficient to promote targeting of the U7 snRNP to chromosomal loops and IGCs. Surprisingly, CBs are only weakly labeled (Fig. 6, A and B; arrows). This result was unexpected, as the U7 snRNP is known to accumulate in CBs at very high concentrations (Wu and Gall, 1993; Bellini and Gall, 1998), and suggests that stem loop I is important to regulate the kinetics of U1 snRNP exchange between CBs and the nucleoplasm.
|
We first showed that depletion of the U2 snRNA results in the loss of the U2 snRNP–specific protein U2B'' from the chromosomal loops (Fig. 7). Interestingly, U2B'' was found to relocalize from chromosomes, IGCs, and CBs to nucleoli. The significance of U2B'' relocalization is not known, but we subsequently used it in all of our experiments as a cytological indicator of successful U2 snRNA depletions. Because microinjected DNA oligonucleotides are short lived, we were able to show that newly injected U2 snRNA could reestablish the normal distribution pattern of U2B'' in U2-depleted oocytes (Fig. 8). This result further validates our previous conclusion that association of fluorescent snRNAs with the chromosomal loops reflects the targeting of fully mature snRNPs.
|
|
20 nucleotides upstream of exon–exon junctions (for review see Aguilera, 2005). Such EJCs influence the cellular fate of spliced mRNAs, with which they remain associated during nuclear export and until they are displaced by translating ribosomes. One of the EJC core subunits, Y14 (Bono et al., 2006; Stroupe et al., 2006), is deposited after exon–exon ligation (Kataoka and Dreyfuss, 2004). Importantly, then, deposition of Y14 on nascent transcripts is a reliable indication of splicing activity. To test whether EJCs are present on chromosomal loops, Y14 was expressed in fusion with an HA tag, and its subcellular distribution was analyzed using the anti-HA antibody mAb 3F10. Fig. 9 A shows that upon injection of HA-Y14 transcripts into the cytoplasm of stage V oocytes, a protein with the expected molecular mass of
24 kD is synthesized and efficiently recruited to the nucleus.
There, it associates with CBs, IGCs as previously reported in somatic nuclei (Degot et al., 2004), and, to a lesser extent, with nucleoli. In addition and in agreement with the fact that pre-mRNA splicing occurs cotranscriptionally, Y14 also associates with nascent transcripts. Remarkably, the depletion of U2 snRNA results in a complete loss of Y14 from chromosomal loops (Fig. 9 B), indicating a lack of spliceosomal activity on nascent RNP fibrils. Finally, a cytoplasmic injection of fluorescently labeled U2 snRNAs restores the presence of the U2 snRNP and Y14 on chromosomal loops (Figs. 8 and 9 B). Together, these data show that pre-mRNA splicing occurs on the chromosomal loops in the presence but not in the absence of U2 snRNP.
|
|
| Discussion |
|---|
|
|
|---|
Interestingly, we have shown here that U1(
SS) and U2(
BPS) snRNAs, which cannot hybridize to introns, are assembled into snRNPs and target the nascent transcripts on chromosomal loops. One interpretation is that the respective base pairing of U1 and U2 snRNAs with the 5' SS and BPS is not essential for their association with nascent transcripts in vivo. This is in agreement with previous work showing that initial recruitment of the U1 snRNP to pre-mRNAs appears to be mediated by U1 snRNP proteins in a 5' SS–independent manner (Wilk et al., 1991; Rossi et al., 1996; Du and Rosbash, 2001, 2002; Lacadie and Rosbash, 2005). In addition, an in vitro study showed that hybridization of the U1 snRNA to target pre-mRNAs is dispensable for early intermediate formation and intron removal (Wilk et al., 1991). In particular, the U1 snRNP was recently shown to be cotranscriptionally recruited to pre-mRNAs with mutations in the 5' SS that abolish hybridization with the U1 snRNA (Lacadie and Rosbash, 2005), suggesting that the 5' SS/U1 snRNA base pairing occurs after an initial recruitment phase (Du and Rosbash, 2001; Lund and Kjems, 2002).
Another possibility stems from the structural organization of the chromosomal loops. In amphibian oocytes, the RNAPII loops are readily visible by light microscopy because of their dense RNP matrix, which is composed of the nascent RNAPII transcripts and associated maturation factors. Surprisingly, some of these factors, such as the 3' end processing factor CstF77, are only involved in the late steps of pre-mRNA maturation (Takagaki and Manley, 1994). Therefore, the presence of CstF77 over the entire length of the loops (Gall et al., 1999) suggests that some pre-mRNA processing factors might associate with nascent RNP particles but remain inactive until the occurrence of their corresponding cis-acting RNA elements. Thus, the efficient recruitment of U1(
SS) and U2(
BPS) snRNPs to nascent transcripts could be the result of a staging event in which snRNPs would first be recruited to the nascent RNP fibrils and be maintained there until spliceosomal assembly could occur. In this model, the initial recruitment of snRNPs would rely, in part, on already associated heterogeneous nuclear RNPs, such as the SR proteins, whose presence was previously shown to require intronic sequences on the pre-mRNA (Huang and Spector, 1996).
U1 snRNP intranuclear trafficking depends on stem loop I
We show here that deletion of the first 47 nucleotides of U1 snRNA, which contain both the 5' SS recognition sequence and stem loop I, has a dramatic effect on its subnuclear distribution. The resulting U1(
47) snRNP still accumulates strongly within CBs, but it fails to target IGCs and the chromosomal loops. Although these data demonstrate that a discrete region of U1 snRNA is critical for its intranuclear trafficking, it also raises the question of how stem loop I regulates the association of the U1 snRNP with two subnuclear domains that are distinct in structure and functions. The lack of association of the U1(
47) snRNP with nascent RNP fibrils could to be caused, in part, by the fact that the U1C protein cannot associate with the U1(
47) snRNA in the absence of stem loop I (Du and Rosbash, 2002). U1C was previously implicated in the binding of pre-mRNAs by the U1 snRNP (Rossi et al., 1996; Chen et al., 2001; Förch et al., 2002), and, thus, its absence from a U1(
47) snRNP could result in the loss of chromosomal targeting. There is no pre-mRNA splicing activity occurring in IGCs, however. Instead, one demonstrated function of these nuclear bodies is to serve as reservoirs for RNAPII maturation factors, which are subsequently recruited to active transcriptional sites (Saitoh et al., 2004; for review see Kiss, 2004). In light of the current model in which newly assembled snRNPs transit through CBs for modification and assembly before their association with IGCs (Gall et al., 1999; Stanek and Neugebauer, 2006; for review see Kiss, 2004), an attractive possibility is that stem loop I is essential to regulate kinetic exchanges of the U1 snRNP between CBs and the nucleoplasm. In particular, stem loop I might be essential for U1 snRNP to exit CBs. Interestingly, we showed that stem loop I is not only sufficient to direct the association of the nonspliceosomal U7 snRNP to nascent transcripts and IGCs, but it also modifies the association of the U7 snRNP with CBs. Indeed, although the normal fluorescent U7 snRNP accumulates greatly in CBs, this association is dramatically reduced by its fusion with stem loop I. Importantly, the chromosomal association of chimeric U7/U1(I) snRNP demonstrates that a snRNP, which cannot participate in splicing, can be targeted to nascent transcripts. In agreement with this idea, we find that both U2(
BPS) and U2(
29) snRNPs, which are nonfunctional (Parker et al., 1987; Wu and Manley, 1989; Zhuang and Weiner, 1989; Yu et al., 1998), are recruited efficiently to nascent transcripts.
The recruitment of snRNPs onto nascent transcripts is splicing independent
A model in which the recruitment of snRNPs and spliceosomal assembly are uncoupled in vivo is further supported by our finding that the U1 snRNP and U4/U6.U5 tri-snRNP still associate with the chromosomal loops when pre-mRNA splicing is inhibited by depletion of the U2 snRNA. Because current paradigms for spliceosome assembly command a stable binding of the U2 snRNP to the BPS before engagement of the U4/U6.U5 tri-snRNP, a likely explanation for these data is that the U4/U6.U5 tri-snRNP targets the nascent transcripts but does not engage in splicing even when the cis-acting RNA elements become available during transcription elongation.
However, one cannot exclude two other interesting possibilities. The first one is that the U4/U6.U5 tri-snRNP was previously shown to recognize the 5' SS in the absence of the U2 snRNP in vitro (Konforti and Konarska, 1994). In addition, the U5 snRNP was demonstrated to interact with the 5' SS before the start of splicing (Wyatt et al., 1992), and, more recently, the U4/U6.U5 tri-snRNP together with the U1 snRNP was proposed to comprise part of a very early intermediate that presumably plays an important role in defining the 5' SS (Maroney et al., 2000). Thus, the observed recruitment of the U1 snRNP and tri-snRNP to chromosomal loops in the absence of the U2 snRNP might reflect the formation and stalling of this early intermediate form on nascent transcripts.
The second possibility comes from the development over the last decade of a different model for spliceosome assembly. A large RNP complex named the penta-snRNP containing all five splicing snRNPs in equal stoichiometric abundance and at least 13 other proteins was purified in yeast (Stevens et al., 2002), and a similar complex was found in mammals (Malca et al., 2003). The penta-snRNP forms in the absence of a pre-mRNA template and, thus, challenges the canonical view of stepwise assembly of the spliceosome. Importantly, when supplemented with an snRNP-depleted extract, the penta-snRNP was competent to splice synthetic substrates as a unitary particle, providing evidence for a preassembly model of splicing wherein all five snRNPs engage the pre-mRNA in one step as a single complex (Stevens et al., 2002). Therefore, another interpretation of the U1 snRNP and tri-snRNP association with chromosomal loops in the absence of splicing is that snRNPs are recruited to the nascent transcripts as part of a preassembled complex. In that case, however, one would have to assume that such a complex could be formed and recruited to the transcriptional units without the U2 snRNP.
Interestingly, a model in which the splicing machinery is staged directly on the transcriptional unit implies some level of preassembly of the splicing machinery before or directly onto the nascent RNP fibrils. Importantly, such a paradigm does not antagonize the canonical view of an ordered assembly process of the spliceosome onto intronic sequences, as the various spliceosomal intermediates could form by recruitment of the splicing factors already associated with nascent transcripts onto the cis-acting RNA elements during transcription elongation.
EJCs associate with the active RNAPII transcriptional units of the LBCs
In the course of our study, we used the deposition of EJCs onto nascent transcripts as an indication of splicing, as it allows the simultaneous monitoring on nuclear spreads of all RNAPII transcriptional units in the same oocyte. EJCs are recruited cotranscriptionally by the spliceosome to mark exon–exon junctions after intron removal (for review see Aguilera, 2005), and, accordingly, we demonstrate here that Y14, a subunit of the EJC, targets the numerous LBC lateral loops. In the absence of the U2 snRNA, spliceosomal assembly and, thus, pre-mRNA splicing is inhibited (Pan et al., 1989; Ségault et al., 1995; Yu et al., 1998), which is illustrated on nuclear spreads by the loss of Y14 from LBCs. Interestingly, we recently obtained evidence that Magoh, another EJC subunit, distributes similarly to Y14 in the oocyte. This result was expected, as Y14 and Magoh were shown previously to interact (Bono et al., 2006; Stroupe et al., 2006). We are now currently using the advantageous spatial resolution offered by LBCs together with the fact that these chromosomes can now be visualized in in vivo–like conditions (unpublished data) to characterize the kinetics of the association of Y14, Magoh, and splicing factors with the active transcriptional units.
| Materials and methods |
|---|
|
|
|---|
47), U1(
SS), U2(
29), and U2(
BPS) used for the transcription of fluorescein-labeled RNA were amplified by PCR using the high fidelity Deep VentR DNA Polymerase (New England Biolabs, Inc.) from corresponding human U1 (Wu et al., 1991), amphibian U2 and U5 (Gall et al., 1999), amphibian U7 (Wu and Gall, 1993), or chicken U4B (Hoffman et al., 1986; Gerbi et al., 2003) clones. The templates for producing P32-labeled riboprobes (anti-U2 and -U5) for Northern blotting were amplified with GoTaq DNA Polymerase (Promega). In all cases, the 5' primer used for amplification contains the T3 or T7 promoter for direct transcription with the respective polymerase. Amplified DNA fragments were gel purified using 0.45-mm cellulose acetate spin-X plastic centrifuge tube filters (Corning Inc.). The U2 DNA template was produced by a two-step PCR in which the first step deletes the BPS recognition sequence and two residues on each side (residues 31–40 of the U2 snRNA) and the second step introduces the T3 promoter. The DNA templates for the transcription of fluorescein–U7 snRNA and HA-Y14 mRNA were prepared by linearizing the pUC9/T7-X.l.U7 snRNA vector with PvuII (Invitrogen) and of pcDNA3.1/HA-tagged human Y14 vector with XbaI (Invitrogen). All DNA templates were phenol extracted, ethanol precipitated, and washed with 70% ethanol before transcription.
The DNA primers (Integrated DNA Technologies) used were as follows (T3 and T7 promoters are underlined): U1 (5'-GCAATTAACCCTCACTAAAGGGATACTTACCTGGCAGGGGAG and 3'-CAGGGGAAAGC- GCGAACGCAGTCCCCCAC), U1(
SS) (5'-GCAATTAACCCTCACTAAA- GGGATACCATGATCATGAAG and 3'-CAGGGGAAAGCGCGAACGCAGTCCCCCAC), U1(
47) (5'-CGTAATACGACTCACTATAGGCAGGGCCAGGCTCAGCC and 3'-CAGGGGAAAGCGCGAACGCAGTCCCCCAC), U2 (5'-GCAATTAACCCTCACTAAAGGGATCCTTTCGCCTTTGC and 3'-AAGTGCACCGGTCCTGGAGGT ACTGC), U2(
BPS) first step (5'-ATCGCTTCTCGGCCTTTTGGCTAAGATCAATGTTCTTATCAGTTTAATATCTG and 3'-AAGTGCACCGGTCCTGGAGGTACTGC), U2(
BPS) second step (5'-GCAA- TTAACCCTCACTAAAGGGATCCTTTCGCCTTTGC and 3'-AAGTGCACCGGT- CCTGGAGGTACTGC), U2(
29) (5'-CGAATTAACCCTCACTAAAGGG- AGTGTAGTATCTGTTCTTATC and 3'-AAGTGCACCGGTCCTGGAG- GTACTGC), U4 (5'-TAATACGACTCACTATAGGGAGCTTTGCGCAGT- GGCAGTATC and 3'-CAGTCTCCGTAGAGACTGTCA), U5 (5'-CGG- AATTCAATTAACCCTCACTAAAGGG and 3'-ATACCTGGTGTGAACC- AGGCTTC), U7/U1(I) (5'-ATACCATGATCATGAAGGTGGTTCTCCAAG- TGTTACAGCTC and 3'-TGTGGCTCCTACAGAG), anti-U2 (5'-CGTA- ATACGACTCACTATAGGGAAGTGCACCGGTCCTGGAG and 3'-ATCGCTTCTCGGCCTTTTGG), and anti-U5 (5'-CGTAATACGACTCACTATAGGGTACCTGGTGTGAACCAGGCTT and 3' ATACTCTGGTTTCTCTTCAAATTC and 3'-TGTGGCTCCTACAGAG).
Fluorescently labeled snRNA and mutants were transcribed with T3 or T7 RNA polymerases (Stratagene) in the presence of 125 nM ATP, 62.5 nM GTP, 125 nM CTP, 62.5 nM UTP, 25 nM ChromaTide fluorescein-12–UTP (Invitrogen), and 125 nM m7G(5')ppp(5')G cap analogue (GE Healthcare). P32-labeled riboprobes were transcribed with T7 RNA polymerase (see previous two paragraphs) except that the cap analogue was omitted in the reaction and the fluorescein-coupled UTP was replaced by 50 µCi
-[32P]UTP (GE Healthcare). The HA-Y14 mRNA was transcribed with T7 RNA polymerase similarly except that UTP was present at 125 nM and fluorescein-12–UTP was omitted. Recombinant RNasin Ribonuclease Inhibitor (Promega) was present in all transcription reactions. After 2 h of incubation at 37°C, transcription reactions were treated with RQ1 RNase-free DNase (Promega) for 15 min at 37°C. All labeled RNAs were purified using NucAway Spin columns (Ambion) equilibrated with water. The HA-Y14 mRNA was phenol extracted, ethanol precipitated, washed, and resuspended in water.
Oocytes and microinjection
Female adult Xenopus was anesthetized in 0.15% tricaine methane sulfonate (MS222; Sigma-Aldrich), and fragments of ovary were surgically removed. Oocytes were defolliculated for 2 h at room temperature in saline buffer OR2 (Wallace et al., 1973) containing 0.2% collagenase (type II; Sigma-Aldrich). Stage IV–V oocytes were isolated and maintained in OR2 at 18°C. Oocytes were always injected into the cytoplasm with volumes of 20–30 nL. Glass needles were prepared using a horizontal pipette puller (P-97; Sutter Instrument Co.). All injections were performed under a dissecting microscope (S; Leica) using an injector (nanojet II; Drummond). For snRNP targeting assays,
10–20 fmol of the respective in vitro–made fluorescent snRNAs were injected per oocyte. For the U2 depletion experiments, 50 ng of the following DNA oligonucleotides (Integrated DNA Technologies) were used per oocyte: U2b oligonucleotide (complimentary to residues 28–42 of the U2 snRNA) CAGATACTACACTTG and C oligonucleotide (sequence unrelated to any Xenopus RNA) TCCGGTACCACGACG.
It is noteworthy to mention that the injection of any DNA oligonucleotide into amphibian oocytes has several reversible nonspecific effects, including a transient inhibition of transcription as visualized by a loss of the lateral chromosomal loops and their reformation over time (Tsvetkov et al., 1992). In all experiments, oocytes were thus incubated for a minimum of 18 h after DNA oligonucleotide injection before preparing nuclear spreads to allow for the recovery of their transcriptional activity. When actinomycin D treatment was required to inhibit transcription, oocytes were incubated in OR2 medium containing 10 µg/ml actinomycin D (Sigma-Aldrich).
RNA electrophoresis and Northern blotting
Single nuclei were isolated and homogenized in 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, and 0.2% SDS. Total nuclear RNAs were phenol extracted, ethanol precipitated, and fractionated on an 8 M urea, 1x Tris borate EDTA, and 8% polyacrylamide gel in 1x Tris borate EDTA electrophoresis buffer using an electrophoresis system (Mini-PROTEAN 3; Bio-Rad Laboratories). The RNA was electrophoretically transferred to a Zeta probe membrane (Bio-Rad Laboratories) in 1x Tris acetate EDTA transfer buffer using the Mini Trans-Blot cell (Bio-Rad Laboratories). The RNA was UV cross-linked (12 kJ/cm2) to the membrane using a cross-linker (Spectrolinker; Spectronics Corp.). The membrane was blocked for 10 min with hybridization buffer (171 mM Na2HPO4, 79 mM NaH2PO4, 1 mM EDTA, pH 8.0, and 7% SDS), probed overnight with 32P-labeled antisense U2 and U5 snRNA probes at 106 cpm/ml in hybridization buffer, and washed twice for 30 min with wash buffer (13.7 mM Na2HPO4, 6.3 mM NaH2PO4, 1 mM EDTA, pH 8.0, and 1% SDS). Blocking, hybridization, and washing were performed at 65°C with rotation in an incubator (Isotemp Hybridization; Fisher Scientific). A phosphorscreen was exposed for 1 h and scanned with the Cyclone Storage Phosphor system (PerkinElmer).
Protein expression and Western blotting
To express HA-tagged Y14, 25 nL (0.5 ng/nL) HA-Y14 mRNA was injected into the cytoplasm of stage V oocytes. After a 50-h incubation, 10 oocytes, cytoplasms, or nuclei were hand isolated using jeweler's forceps and homogenized in 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, and 0.2% SDS. The crude extract was centrifuged at 22,000 g at 4°C for 10 min. The clarified extract was collected and fractionated on a 12% polyacrylimide gel using an electrophoresis system (Mini-PROTEAN 3; Bio-Rad Laboratories). Immunoblotting was then performed as described previously (Beenders et al., 2003) with the anti-HA antibody mAb 3F10 (Hoffmann-La Roche, Inc.) used at 50 ng/ml.
Nuclear spreads and immunofluorescence
Nuclear spreads were prepared as described previously (Bellini and Gall, 1998) and fixed with 2% PFA in PBS + 1 mM MgCl2 for 1 h at room temperature. After fixation, nuclear spreads were rinsed in PBS and blocked with 0.5% BSA (Sigma-Aldrich) + 0.5% gelatin (from cold water fish) in PBS (blocking buffer) for 10 min. Spreads were incubated with primary antibody for 1 h at room temperature, washed for 30 min with two changes of PBS, incubated with secondary antibody for 1 h at room temperature, and washed again for 30 min with two changes of PBS before they were mounted in 50% glycerol/PBS containing 1 mg/ml phenylenediamine and 10 pg/ml DAPI. When a red fluorescent DNA counterstain was desired, spread preparations were incubated with 1 µM Syto61 (Invitrogen) in PBS for 20 min at room temperature and briefly rinsed in PBS before mounting. In these preparations, DAPI was omitted from the mounting medium.
Standard fluorescence microscopy was performed using a microscope (DMR; Leica), a PL Fluotar 40x NA 1.0 oil objective (Leica), and a Fluotar 100x NA 1.30 oil objective (Leica). Either a Spot RT monochrome CCD camera (Diagnostic Instruments) or a Retiga EXI monochrome CCD camera (QImaging) was used to capture images with Spot RT software (Diagnostic Instruments) or In Vivo software (version 3.2.0; Media Cybernetics), respectively. Confocal microscopy was performed on a laser-scanning microscope (Axiovert 100M 510; Carl Zeiss MicroImaging, Inc.) and its associated software system. The scans were obtained using a plan Apochromat 63x NA 1.40 oil objective (Carl Zeiss MicroImaging, Inc.). All images were captured at room temperature. Figures were processed using Photoshop CS version 8.0 (Adobe) and assembled with InDesign CS version 3.0 (Adobe).
The antibodies used in this study were all diluted in the blocking buffer. The following AlexaFluor-conjugated antibodies (Invitrogen) were used at a concentration of 2.5 µg/ml: AlexaFluor488 rabbit antifluorescein/Oregon green, AlexaFluor488 goat anti–rabbit IgG, AlexaFluor594 goat anti–mouse IgG, AlexaFluor350 goat anti–mouse IgG, and AlexaFluor488 goat anti–mouse IgG. The AlexaFluor488 mouse antifluorescein IgG (Millipore) was used at 1 µg/ml. The anticoilin antibody mAb H1 was used at 500 ng/ml. The anti-U2B'' antibody mAb 4G8 is a cell supernate and was used at a 1:50 dilution. Anti-RPC53 is a purified rabbit polyclonal serum and was used at a dilution of 1:50,000.
| Acknowledgments |
|---|
This work was supported by a CAREER award from the National Science Foundation (grant 03440066).
Submitted: 20 June 2007
Accepted: 9 August 2007
| References |
|---|
|
|
|---|
Aguilera, A. 2005. Cotranscriptional mRNP assembly: from the DNA to the nuclear pore. Curr. Opin. Cell Biol. 17:242–250.[CrossRef][Medline]
Beenders, B., E. Watrin, V. Legagneux, I. Kireev, and M. Bellini. 2003. Distribution of XCAP-E and XCAP-D2 in the Xenopus oocyte nucleus. Chromosome Res. 11:549–564.[CrossRef][Medline]
Bellini, M., and J.G. Gall. 1998. Coilin can form a complex with the U7 small ribonucleoprotein. Mol. Biol. Cell. 9:2987–3001.
Bentley, D.L. 2005. Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr. Opin. Cell Biol. 17:251–256.[CrossRef][Medline]
Birchmeier, C., D. Schumperli, G. Sconzo, and M.L. Birnstiel. 1984. 3' editing of mRNAs: sequence requirements and involvement of a 60-nucleotide RNA in maturation of histone mRNA precursors. Proc. Natl. Acad. Sci. USA. 81:1057–1061.
Birnstiel, M.L., and F.J. Schaufele. 1988. Structure and function of minor snRNPs. In Structure and Function of Major and Minor Small Nuclear Ribonucleoprotein Particles. M.L. Birnstiel, editor. Springer-Verlag New York Inc., New York. 155–182.
Bono, F., J. Ebert, E. Lorentzen, and E. Conti. 2006. The crystal structure of the exon junction complex reveals how it maintains a stable grip on mRNA. Cell. 126:713–725.[CrossRef][Medline]
Chen, J.Y., L. Stands, J.P. Staley, R.R. Jackups Jr., L.J. Latus, and T.H. Chang. 2001. Specific alterations of U1-C protein or U1 small nuclear RNA can eliminate the requirement of Prp28p, an essential DEAD box splicing factor. Mol. Cell. 7:227–232.[CrossRef][Medline]
Crispino, J.D., B.J. Blencowe, and P.A. Sharp. 1994. Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science. 265:1866–1869.
Crispino, J.D., J.E. Mermoud, A.I. Lamond, and P.A. Sharp. 1996. Cis-acting elements distinct from the 5' splice site promote U1-independent pre-mRNA splicing. RNA. 2:664–673.[Abstract]
Degot, S., H. Le Hir, F. Alpy, V. Kedinger, I. Stoll, C. Wendling, B. Seraphin, M.C. Rio, and C. Tomasetto. 2004. Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module. J. Biol. Chem. 279:33702–33715.
Dominski, Z., J.A. Erkmann, X. Yang, R. Sanchez, and W.F. Marzluff. 2002. A novel zinc finger protein is associated with U7 snRNP and interacts with the stem-loop binding protein in the histone pre-mRNP to stimulate 3'-end processing. Genes Dev. 16:58–71.
Donmez, G., K. Hartmuth, and R. Luhrmann. 2004. Modified nucleotides at the 5' end of human U2 snRNA are required for spliceosomal E-complex formation. RNA. 10:1925–1933.
Du, H., and M. Rosbash. 2001. Yeast U1 snRNP-pre-mRNA complex formation without U1snRNA-pre-mRNA base pairing. RNA. 7:133–142.[Abstract]
Du, H., and M. Rosbash. 2002. The U1 snRNP protein U1C recognizes the 5' splice site in the absence of base pairing. Nature. 419:86–90.[CrossRef][Medline]
Förch, P., O. Puig, C. Martinez, B. Seraphin, and J. Valcarcel. 2002. The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5' splice sites. EMBO J. 21:6882–6892.[CrossRef][Medline]
Fu, X.-D., and T. Maniatis. 1990. Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature. 343:437–441.[CrossRef][Medline]
Gall, J.G. 2003. The centennial of the Cajal body. Nat. Rev. Mol. Cell Biol. 4:975–980.[CrossRef][Medline]
Gall, J.G., M. Bellini, Z. Wu, and C. Murphy. 1999. Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes. Mol. Biol. Cell. 10:4385–4402.
Gerbi, S.A., A.V. Borovjagin, F.E. Odreman, and T.S. Lange. 2003. U4 snRNA nucleolar localization requires the NHPX/15.5-kD protein binding site but not Sm protein or U6 snRNA association. J. Cell Biol. 162:821–832.
Grimm, C., B. Stefanovic, and D. Schumperli. 1993. The low abundance of U7 snRNA is partly determined by its Sm binding site. EMBO J. 12:1229–1238.[Medline]
Hastings, M.L., and A.R. Krainer. 2001. Pre-mRNA splicing in the new millennium. Curr. Opin. Cell Biol. 13:302–309.[CrossRef][Medline]
Hoffman, M.L., G.M. Korf, K.J. McNamara, and W.E. Stumph. 1986. Structural and functional analysis of chicken U4 small nuclear RNA genes. Mol. Cell Biol. 6:3910–3919.
Huang, S., and D.L. Spector. 1996. Intron-dependent recruitment of pre-mRNA splicing factors to sites of transcription. J. Cell Biol. 133:719–732.
Kataoka, N., and G. Dreyfuss. 2004. A simple whole cell lysate system for in vitro splicing reveals a stepwise assembly of the exon-exon junction complex. J. Biol. Chem. 279:7009–7013.
Kiss, T. 2004. Biogenesis of small nuclear RNPs. J. Cell Sci. 117:5949–5951.
Konforti, B.B., and M.M. Konarska. 1994. U4/U5/U6 snRNP recognizes the 5' splice site in the absence of U2 snRNP. Genes Dev. 8:1962–1973.
Krämer, A., W. Keller, B. Appel, and R. Luhrmann. 1984. The 5' terminus of the RNA moiety of U1 small nuclear ribonucleoprotein particles is required for the splicing of messenger RNA precursors. Cell. 38:299–307.[CrossRef][Medline]
Lacadie, S.A., and M. Rosbash. 2005. Cotranscriptional spliceosome assembly dynamics and the role of U1 snRNA:5'ss base pairing in yeast. Mol. Cell. 19:65–75.[CrossRef][Medline]
Lund, M., and J. Kjems. 2002. Defining a 5' splice site by functional selection in the presence and absence of U1 snRNA 5' end. RNA. 8:166–179.[Abstract]
Malca, H., N. Shomron, and G. Ast. 2003. The U1 snRNP base pairs with the 5' splice site within a penta-snRNP complex. Mol. Cell. Biol. 23:3442–3455.
Maroney, P.A., C.M. Romfo, and T.W. Nilsen. 2000. Functional recognition of 5' splice site by U4/U6.U5 tri-snRNP defines a novel ATP-dependent step in early spliceosome assembly. Mol. Cell. 6:317–328.[CrossRef][Medline]
Matera, A.G., and K.B. Shpargel. 2006. Pumping RNA: nuclear bodybuilding along the RNP pipeline. Curr. Opin. Cell Biol. 18:317–324.[CrossRef][Medline]
Mattaj, I.W. 1988. UsnRNP assembly and transport. In Structure and Function of Major and Minor Small Nuclear Ribonucleoprotein Particles. M.L. Birnstiel, editor. Springer-Verlag New York Inc., New York. 100–114.
Morgan, G.T. 2002. Lampbrush chromosomes and associated bodies: new insights into principles of nuclear structure and function. Chromosome Res. 10:177–200.[CrossRef][Medline]
Mowry, K.L., and J.A. Steitz. 1987. Identification of the human U7 snRNP as one of several factors in the 3' end maturation of histone premessenger RNAs. Science. 238:1682–1687.
Murphy, C., Z. Wang, R.G. Roeder, and J.G. Gall. 2002. RNA polymerase III in Cajal bodies and lampbrush chromosomes of the Xenopus oocyte nucleus. Mol. Biol. Cell. 13:3466–3476.
Nelissen, R.L., C.L. Will, W.J. van Venrooij, and R. Luhrmann. 1994. The association of the U1-specific 70K and C proteins with U1 snRNPs is mediated in part by common U snRNP proteins. EMBO J. 13:4113–4125.[Medline]
Neugebauer, K.M. 2002. On the importance of being co-transcriptional. J. Cell Sci. 115:3865–3871.
Pan, Z.-Q., and C. Prives. 1988. Assembly of functional U1 and U2 human-amphibian hybrid snRNPs in Xenopus laevis oocytes. Science. 241:1328–1331.
Pan, Z.Q., H. Ge, X.Y. Fu, J.L. Manley, and C. Prives. 1989. Oligonucleotide-targeted degradation of U1 and U2 snRNAs reveals differential interactions of simian virus 40 pre-mRNAs with snRNPs. Nucleic Acids Res. 17:6553–6568.
Parker, R., P.G. Siliciano, and C. Guthrie. 1987. Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell. 49:229–239.[CrossRef][Medline]
Patel, A.A., and J.A. Steitz. 2003. Splicing double: insights from the second spliceosome. Nat. Rev. Mol. Cell Biol. 4:960–970.[CrossRef][Medline]
Rossi, F., T. Forne, E. Antoine, J. Tazi, C. Brunel, and G. Cathala. 1996. Involvement of U1 small nuclear ribonucleoproteins (snRNP) in 5' splice site-U1 snRNP interaction. J. Biol. Chem. 271:23985–23991.
Saitoh, N., C.S. Spahr, S.D. Patterson, P. Bubulya, A.F. Neuwald, and D.L. Spector. 2004. Proteomic analysis of interchromatin granule clusters. Mol. Biol. Cell. 15:3876–3890.
Scharl, E., and J. Steitz. 1994. The site of 3' end formation of histone messenger RNA is a fixed distance from the downstream element recognized by the U7 snRNP. EMBO J. 13:2432–2440.[Medline]
Ségault, V., C.L. Will, B.S. Sproat, and R. Luhrmann. 1995. In vitro reconstitution of mammalian U2 and U5 snRNPs active in splicing: Sm proteins are functionally interchangeable and are essential for the formation of functional U2 and U5 snRNPs. EMBO J. 14:4010–4021.[Medline]
Stanek, D., and K.M. Neugebauer. 2006. The Cajal body: a meeting place for spliceosomal snRNPs in the nuclear maze. Chromosoma. 115:343–354.[CrossRef][Medline]
Stefanovic, B., W. Hackl, R. Luhrmann, and D. Schumperli. 1995. Assembly, nuclear import and function of U7 snRNPs studied by microinjection of synthetic U7 RNA into Xenopus oocytes. Nucleic Acids Res. 23:3141–3151.
Stevens, S.W., D.E. Ryan, H.Y. Ge, R.E. Moore, M.K. Young, T.D. Lee, and J. Abelson. 2002. Composition and functional characterization of the yeast spliceosomal penta-snRNP. Mol. Cell. 9:31–44.[CrossRef][Medline]
Stroupe, M.E., T.O. Tange, D.R. Thomas, M.J. Moore, and N. Grigorieff. 2006. The three-dimensional architecture of the EJC core. J. Mol. Biol. 360:743–749.[CrossRef][Medline]
Surowy, C.S., V.L. van Santen, S.M. Scheib-Wixted, and R.A. Spritz. 1989. Direct, sequence-specific binding of the human U1-70K ribonucleoprotein antigen protein to loop I of U1 small nuclear RNA. Mol. Cell. Biol. 9:4179–4186.
Takagaki, Y., and J.L. Manley. 1994. A polyadenylation factor subunit is the human homologue of the Drosophila suppressor of forked protein. Nature. 372:471–474.[CrossRef][Medline]
Tsvetkov, A., M. Jantsch, Z. Wu, C. Murphy, and J.G. Gall. 1992. Transcription on lampbrush chromosome loops in the absence of U2 snRNA. Mol. Biol. Cell. 3:249–261.[Abstract]
Wallace, R.A., D.W. Jared, J.N. Dumont, and M.W. Sega. 1973. Protein incorporation by isolated amphibian oocytes. 3. Optimum incubation conditions. J. Exp. Zool. 184:321–333.[CrossRef][Medline]
Wilk, H.E., K.P. Schaefer, P.F. Agris, A.M. Boak, and S.A. Kovacs. 1991. U1 SnRNP association with HnRNP involves an initial non-specific splice-site independent interaction of U1 SnRNP protein with HnRNA. Mol. Cell. Biochem. 106:55–66.[CrossRef][Medline]
Will, C.L., and R. Luhrmann. 2001. Spliceosomal UsnRNP biogenesis, structure and function. Curr. Opin. Cell Biol. 13:290–301.[CrossRef][Medline]
Wu, C.-H., and J.G. Gall. 1993. U7 small nuclear RNA in C snurposomes of the Xenopus germinal vesicle. Proc. Natl. Acad. Sci. USA. 90:6257–6259.
Wu, C.-H., C. Murphy, and J.G. Gall. 1996. The Sm binding site targets U7 snRNA to coiled bodies (spheres) of amphibian oocytes. RNA. 2:811–823.[Abstract]
Wu, J., and J.L. Manley. 1989. Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing. Genes Dev. 3:1553–1561.
Wu, Z., C. Murphy, H.G. Callan, and J.G. Gall. 1991. Small nuclear ribonucleoproteins and heterogeneous nuclear ribonucleoproteins in the amphibian germinal vesicle: loops, spheres, and snurposomes. J. Cell Biol. 113:465–483.
Wyatt, J.R., E.J. Sontheimer, and J.A. Steitz. 1992. Site-specific cross-linking of mammalian U5 snRNP to the 5' splice site before the first step of pre-mRNA splicing. Genes Dev. 6:2542–2553.
Yu, Y.T., M.D. Shu, and J.A. Steitz. 1998. Modifications of U2 snRNA are required for snRNP assembly and pre-mRNA splicing. EMBO J. 17:5783–5795.[CrossRef][Medline]
Zhuang, Y., and A.M. Weiner. 1989. A compensatory base change in human U2 snRNA can suppress a branch site mutation. Genes Dev. 3:1545–1552.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|